Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

Saint-Louis, France and Dublin, Ireland - 3rd June 2025- Priothera Ltd., a late-stage biopharma company pioneering the ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical ...

JNJ's 62-year streak of dividend growth, 3.4% yield, and disciplined capital allocation make it highly attractive for ...

What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet ...